Back

MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology in acute coronary syndromes (2) Vulnerable Plaque ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ping Sun

The Second Affiliated Hospital of Harbin Medical University, Harbin (China)

6 More presentations in this session

Presentation thumbnail
The natural history of arterial thrombus healing after superficial plaque erosion in an atherosclerotic rabbit model
Doctor K. Hashimoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Metformin attenuates post-infarction cardiac remodelling in rats, associated with changes in oxidative stress, energy metabolism, gut microbiota and metabolomics
Doctor D. Queiroz (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Gut virome alterations in AMI pathogenesis
Doctor W. Wei (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Endothelin-1 receptor type A agonistic autoantibodies and cardiac arrest: new evidence in STEMI
Doctor G. Civieri (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Prolonged mast cell stabilization in reperfused myocardial infarction accelerates hemorrhage resorption and improves remodeling
Doctor L. Riehakainen (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Profiling the L-arginine/arginase 1 metabolism in early and advanced atherosclerosis
thumbnail
Congress Presentation
SET7 lysine methyltransferase mediates NLRP3 inflammasome priming and activation in atherosclerotic apolipoprotein E knockout mice
thumbnail
Congress Presentation
Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources